» Articles » PMID: 17163462

Health-related Quality of Life Profiles Based on Survivorship Status for Head and Neck Cancer Patients

Overview
Journal Head Neck
Date 2006 Dec 14
PMID 17163462
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As the methodologies for evaluating health-related quality of life (HRQOL) in head and neck cancer patients have matured over the past 10 years, there has been an increasing focus on reporting longitudinal data. These studies have primarily focused on long-term survivors. This study addresses the HRQOL of both long-term and short-term survivors.

Methods: This is a prospective, longitudinal study of 479 head and neck cancer patients followed for at least 3 years after diagnosis. Analysis of longitudinally collected HRQOL scores was based on survivorship status.

Results: The HRQOL for 3 survivorship groups: short-term (died <1 year), intermediate-term (died 1-3 years), and long-term survivors (alive >3 years) were different at all time points (pretreatment, 3, 6, and 12 months). Differences were greatest between the short-term and long-term survivors. Long-term survivors demonstrated the best HRQOL and an improving HRQOL trajectory at 12 months. The HRQOL of short-term survivors declined precipitously throughout all available follow-up. Intermediate-term survivors did show some improvement following treatment but had a declining HRQOL trajectory at 12 months.

Conclusion: The HRQOL profiles of head and neck cancer patients differed significantly depending on survivorship status. Long-term HRQOL results should be analyzed within the context of the results for all of the patients eligible to have been included in the initial study cohort.

Citing Articles

Prevalence and persistence of depressive symptoms during the first year postdiagnosis in a large sample of patients with head and neck cancer.

Howren M, Christensen A, Pagedar N Am J Otolaryngol. 2024; 45(3):104257.

PMID: 38518447 PMC: 11070284. DOI: 10.1016/j.amjoto.2024.104257.


Feasibility of DW-MRI analysis of salivary glands during head and neck radiotherapy.

Duffton A, Kemp O, Devlin L, Hay L, McLoone P, Paterson C Tech Innov Patient Support Radiat Oncol. 2021; 19:46-51.

PMID: 34527819 PMC: 8430428. DOI: 10.1016/j.tipsro.2021.07.002.


Health-related quality of life and overall survival: a prospective study in patients with head and neck cancer treated with radiotherapy.

van Nieuwenhuizen A, Buffart L, Langendijk J, Vergeer M, Voortman J, Leemans C Qual Life Res. 2020; 30(4):1145-1153.

PMID: 33289866 PMC: 8004520. DOI: 10.1007/s11136-020-02716-x.


Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.

Huang V, Imam S, Nguyen S Head Neck. 2020; 42(7):1664-1667.

PMID: 32358880 PMC: 7267631. DOI: 10.1002/hed.26235.


Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

Nguyen Q, Chun S, Chow E, Komaki R, Liao Z, Zacharia R JAMA Oncol. 2019; 5(6):872-878.

PMID: 31021390 PMC: 6487911. DOI: 10.1001/jamaoncol.2019.0192.